XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Balance Sheets - USD ($)
shares in Thousands, $ in Millions
Jun. 30, 2019
Dec. 31, 2018
Assets    
Cash and Due from Banks $ 3,752 $ 5,791
Federal Funds Sold and Securities Purchased under Agreements to Resell 1,251 1,679
Interest-bearing Deposits in Banks and Other Financial Institutions 25 25
Cash and cash equivalents 5,028 7,495
Debt Securities, Trading, and Equity Securities, FV-NI [1] 6,610 5,506
Available-for-sale Securities [2] 32,487 31,442
Loans Held for Sale [3] 2,229 1,468
Loans held for investment 156,589 151,839
Loans and Leases Receivable, Allowance (1,681) (1,615)
Net loans 154,908 150,224
Property, Plant and Equipment, Net 1,963 2,024
Goodwill 6,331 6,331
Intangible Assets, Net (Excluding Goodwill) 1,796 2,062
Other Assets 10,936 8,991
Total assets 222,288 215,543
Liabilities and Shareholders' Equity    
Noninterest-bearing consumer and commercial deposits 39,850 40,770
Interest-bearing Deposit Liabilities 121,282 121,819
Total deposits 161,132 162,589
Federal Funds Purchased 314 2,141
Securities Sold under Agreements to Repurchase 1,814 1,774
Other Short-term Borrowings 7,396 4,857
Long-term Debt [4] 20,200 15,072
Trading liabilities 1,294 1,604
Other Liabilities 4,276 3,226
Total liabilities 196,426 191,263
Preferred Stock, Value, Outstanding 2,025 2,025
Common Stock, Value, Outstanding 553 553
Additional Paid in Capital 8,965 9,022
Retained earnings 20,319 19,522
Treasury Stock, Value [5] (5,599) (5,422)
Accumulated Other Comprehensive Income (Loss), Net of Tax (401) (1,420)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 25,862 24,280
Liabilities and Equity $ 222,288 $ 215,543
Common Stock, Shares, Outstanding [6] 443,858 446,888
Common shares authorized 750,000 750,000
Preferred Stock, Shares Outstanding 20 20
Preferred Stock, Shares Authorized 50,000 50,000
Treasury shares of common stock 108,926 105,896
Treasury Stock and Other    
Liabilities and Shareholders' Equity    
Treasury Stock, Value $ (5,702)  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [7] (5,599) $ (5,422)
Stockholders' Equity Attributable to Noncontrolling Interest 103 103
Variable Interest Entity, Primary Beneficiary [Member]    
Assets    
Loans held for investment 141 153
Liabilities and Shareholders' Equity    
Long-term Debt $ 149 $ 161
Restricted Stock [Member]    
Liabilities and Shareholders' Equity    
Common Stock, Shares, Outstanding 4 7
Trading Assets [Member]    
Liabilities and Shareholders' Equity    
Pledged Assets Separately Reported, Securities Pledged as Collateral, at Fair Value $ 1,214 $ 1,442
Available-for-sale Securities [Member]    
Liabilities and Shareholders' Equity    
Pledged Assets Separately Reported, Securities Pledged as Collateral, at Fair Value $ 212 $ 222
[1] Includes trading securities pledged as collateral where counterparties have the right to sell or repledge the collateral of $1,214 million and $1,442 million at June 30, 2019 and December 31, 2018, respectively.
[2] Includes securities AFS pledged as collateral where counterparties have the right to sell or repledge the collateral of $212 million and $222 million at June 30, 2019 and December 31, 2018, respectively.
[3] Includes $1.7 billion and $1.2 billion of LHFS measured at fair value at June 30, 2019 and December 31, 2018, respectively.
[4] Includes debt of consolidated VIEs of $149 million and $161 million at June 30, 2019 and December 31, 2018, respectively.
[5] Includes noncontrolling interest of $103 million and $103 million at June 30, 2019 and December 31, 2018, respectively.
[6] Includes restricted shares of 4 thousand and 7 thousand at June 30, 2019 and December 31, 2018, respectively.
[7] At June 30, 2019, includes ($5,702) million for treasury stock and $103 million for noncontrolling interest.
At March 31, 2019, includes ($5,710) million for treasury stock and $101 million for noncontrolling interest.